CONTEXT
It has been suggested that specific regulation of laboratories performing genetic testing may be needed to ensure standards and quality assurance, and to safeguard the rights of patients with regard to confidentiality and providing informed consent. Previously, a comprehensive analysis of current practices of molecular genetic testing laboratories was conducted, the results of which have assisted in the assessment of the need for regulation and its impact on access to testing. However, a study designed to determine clinical laboratory practices with regard to biochemical genetic testing has not been carried out.
OBJECTIVE
To collect and analyze data regarding availability of clinical biochemical genetic testing, personnel standards, and laboratory quality assurance practices.
DESIGN
A mail survey of biochemical genetic testing laboratory directors and assignment of a quality assurance score based on responses to genetic testing process items.
SETTING
Hospital-based, independent, and research-based biochemical genetic testing laboratories in the United States.
PARTICIPANTS
Directors of biochemical genetic testing laboratories (n = 133; response rate 68.5%).
MAIN OUTCOME MEASURE
Laboratory process quality assurance score based on the standards defined by the American College of Medical Genetics Laboratory Practice Committee.
RESULTS
Personnel qualifications varied, although all directors had doctoral degrees. The mean quality assurance score was 77% (range 28%-100%). Higher scores were associated with the following variables: test director having an MD degree versus PhD degree (P = .002), director board certification in biochemical genetics (P = .002), research and hospital laboratory versus independent laboratory setting (P < .001), and participation in a proficiency testing program (P = .03). Twelve percent of participants had a confidentiality policy, and 19% required informed consent before testing.
CONCLUSION
The finding that a number of laboratories had quality assurance scores that may reflect suboptimal laboratory practices, particularly with regard to reporting practices, suggests that personnel qualification and laboratory practice standards may be in need of improvement to ensure quality in clinical biochemical genetic testing laboratories, as well as the appropriate clinical use of the test results.
[1]
S. Gygi,et al.
Mass spectrometry and proteomics.
,
2000,
Current opinion in chemical biology.
[2]
P. Clayton.
Applications of mass spectrometry in the study of inborn errors of metabolism
,
2001,
Journal of Inherited Metabolic Disease.
[3]
R. Desnick,et al.
Quality assurance in molecular genetic testing laboratories.
,
1999,
JAMA.
[4]
P. Rinaldo,et al.
Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation
,
2001,
Prenatal diagnosis.
[5]
D. L. Norwood,et al.
Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism
,
1990,
Journal of Inherited Metabolic Disease.
[6]
S. Packman,et al.
USE OF AMNIOTIC FLUID AMINO ACIDS IN PRENATAL TESTING FOR ARGININOSUCCINIC ACIDURIA AND CITRULLINAEMIA
,
1996,
Prenatal diagnosis.
[7]
Holtzman Na,et al.
Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing.
,
1999,
Journal of child and family nursing.
[8]
Fung Et,et al.
Proteomic strategies for biomarker identification: progress and challenges.
,
2000
.
[9]
M. A. Brewster,et al.
Proficiency testing for biochemical genetics laboratories: the first 10 rounds of testing.
,
1990,
American journal of human genetics.
[10]
D. Chace,et al.
Automated Tandem Mass Spectrometry for Mass Newborn Screening for Disorders in Fatty Acid, Organic Acid, and Amino Acid Metabolism
,
1999,
Journal of child neurology.
[11]
G I Murray,et al.
Proteomics: a new approach to the study of disease
,
2000,
The Journal of pathology.
[12]
J. Connor,et al.
PRENATAL DIAGNOSIS BY ENZYME ANALYSIS IN 15 PREGNANCIES AT RISK FOR THE LESCH–NYHAN SYNDROME
,
1996,
Prenatal diagnosis.
[13]
Michael M. Kaback,et al.
Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model
,
2000,
European Journal of Pediatrics.